Stock·NASDAQ·Communication Services
Charter Communications (CHTR)
- Market cap
- $13.63B
- P/E
- 2.73
- Dividend yield
- None
- Street target
- $145.00median of 21 analysts
- 52-week range
- $101.11 $254.11
CHTR stock forecast today
Where CHTR stands today, and what CleaRank Financial AI makes of it.
CHTR at a glance
Charter Communications (CHTR): Sell, 39/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($126.67 and $166.30).
- Earnings CHTR beat estimates in 5 of the 7 reports in our data, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $13.7M and bought $4.9M over the last 18 months.
- Valuation P/E of 2.7 against 23.3 for the Communication Services sector: a discount to peers (-88%).
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Charter Communications (CHTR) Sell, with a model score of 39/100.
Valuation lifts the score most: the P/E of 2.73 is 88.3% below the sector median (a discount to peers) and the P/S of 0.25 is 90.0% below the sector median. The trend holds it back most: the price is 36.91% below its 200-day average and 17.18% below its 50-day average, and the 50-day average is 23.83% below the 200-day. The 50-day average stands at $126.67 and the 200-day at $166.30. Over the past year the price fell 57.25%.
Only on CleaRank
Figures we compute ourselves from CHTR's own price, earnings and insider-filing history. Tap one to see it in context.
CHTR stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $104.92 is 17.2% below the 50-day simple moving average of $126.67.Price above its 200-day average ›
The price is 36.9% below the 200-day simple moving average of $166.30.50-day average above the 200-day ›
The 50-day average ($126.67) is 23.8% below the 200-day average ($166.30), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 2% of its 52-week range, between $101.11 and $254.11.
CHTR share price
Pick a period: each tab shows how far CHTR has moved over it, to the last close.
Today's trading
Where CHTR sits inside today's range and its 52-week range.
CHTR fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/4P/E below the sector median ›
The trailing P/E of 2.73 is 88.3% below the Communication Services median of 23.3.P/S below the sector median ›
The price-to-sales ratio of 0.25 is 90.0% below the sector median of 2.5.Profitable over the last 12 months ›
Net income over the last 12 months was $5.7B on revenue of $54.4B, a net margin of 10.6%.Beat estimates in most recent reports ›
CHTR beat the EPS estimate in 5 of the 7 reports in our data.
Key statistics
The headline figures for CHTR.
As of October 27, 2026, CHTR trades at $104.92, with a market value of $13.63B and a P/E ratio of 2.73.
What the numbers say
CleaRank Financial AI's reading of CHTR's valuation, growth and risks.
CHTR is valued at 2.73 times earnings, compared with a sector median of 23.3 for Communication Services, which makes the P/E a discount to peers, sitting 88.3% below that median. Measured on sales, the P/S of 0.25 is 90.0% below the sector median of 2.5. The company carries a market value of $13.6B, and its trailing earnings come to $38.41 a share.
In the latest quarter, against the same quarter a year earlier, revenue fell 1.70%, 15.6 percentage points slower than the sector median of 13.9%. Margins stand at a net margin of 10.6% and an operating margin of 23.50%. It reports a return on equity of 27.20%, above the sector median of 15.8%. Debt-to-equity of 4.42 rounds out the fundamentals.
The July 24, 2026 report beat expectations by 5.96%: $10.66 a share against a $10.06 estimate. The market agreed: the stock rose 6.73% the following session.
The earnings record shows 5 beats in 7 reports, though the stock still fell in the first session after 1 of those 5 beats. Analysts' average EPS estimate for this fiscal year is $40.36, which would be growth of 11.5%, and $44.63 for next year (growth of 10.6%).
CHTR's daily returns have a 30-day standard deviation of 2.78%, and its beta against the S&P 500 is 0.69. As long as the price stays under both moving averages, the downtrend remains a risk in itself. The stock is 58.71% below its 52-week high of $254.11. Insider sales over the last 18 months totalled $13.7M, while open-market purchases came to $4.9M. Insider sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than buying does.
CHTR against the Communication Services sector
How CHTR compares with the median Communication Services stock CleaRank tracks.
Price to earnings vs sector: CHTR trades at a notable discount to sector peers (-88%), which may indicate undervaluation or specific company headwinds.
Return vs XLC: Since May 15, 2025, CHTR has lost 75.0% against a gain of 2.5% for XLC.
Performance against XLC
CHTR and the Communication Services sector fund over the same days.
Revenue and earnings
How much CHTR sells, and how much of it becomes profit.
Revenue growth: Revenue fell 0.6% in FY2025 to $54.8B, from $55.1B a year earlier.
Profit margin: The net margin was 10.5% in FY2025, down from 10.6% the year before.
Profitable: CHTR earned $5.8B in FY2025.
Earnings reality check
Did CHTR beat what analysts expected, and how did the stock react?
Earnings record: CHTR beat the analyst estimate in 5 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 1 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 24, 2026after close | $10.06 | $10.66 | +5.96% | +6.73% | +17.57% |
| Jan 30, 2026after close | $9.93 | $10.34 | +4.13% | +3.63% | +12.14% |
| Oct 31, 2025after close | $9.29 | $8.34 | -10.23% | -4.98% | -5.98% |
| Jul 25, 2025after close | $9.66 | $9.18 | -4.97% | -3.71% | -14.55% |
| Apr 25, 2025after close | $8.37 | $8.42 | +0.60% | +0.86% | +3.04% |
| Jan 31, 2025after close | $9.22 | $10.10 | +9.54% | -1.15% | +0.68% |
| Nov 1, 2024after close | $8.49 | $8.82 | +3.89% | +2.55% | +7.43% |
As of October 27, 2026, CHTR has beaten the analyst EPS estimate in 5 of the 7 reports in our data and fell in the first trading session after 1 of those beats; its latest report, on July 24, 2026, came in 5.96% above the estimate and the stock moved +6.73% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CHTR AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 39.9, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 39.9 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of CHTR
The score, the reasoning behind it, and what could move the price next.
Both moving averages sit above the price, the shape of a downtrend for CHTR: the price of $104.92 is 17.18% below the 50-day average ($126.67) and 36.91% below the 200-day average ($166.30). At 2% of its 52-week range, the price is 3.76% above the 52-week low of $101.11. The averages agree: the 50-day is 23.83% below the 200-day.
On momentum, the 14-day RSI reads 39.9, in the bearish zone, above the oversold line, with the MACD line negative. The recent returns all show a loss, with the price down 25.04% over the past three months, 39.39% over the past six months and 57.25% over the past year.
Earnings beat ›
The July 24, 2026 report beat the EPS estimate by 5.96%, and the share price rose 6.73% in the first session after it.
Source: Earnings report, July 24, 2026
Analyst downgrade ›
Wolfe Research downgraded it to Underperform from Peer Perform on September 14, 2026.
Source: Analyst action, Wolfe Research, September 14, 2026
New analyst coverage ›
Morgan Stanley restarted coverage at Equal-Weight on September 14, 2026.
Source: Analyst action, Morgan Stanley, September 14, 2026
- Two levels matter most: the 20-day EMA at $110.30 sits above the price, and the 52-week low at $101.11 sits below it.
- A 14-day RSI of 39.9 sits in the bearish zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- CHTR rose 6.73% in the first session after its July 24, 2026 report. Across the 7 reports in our data, the company beat estimates in 5 of them.
CHTR stays in a downtrend for as long as it trades below both its 50-day average of $126.67 and its 200-day average of $166.30. A close back above the 50-day would be the first sign of repair. Overhead, the 20-day EMA at $110.30 is the first hurdle a rally would meet.
The next level below the price is the 52-week low of $101.11. With the RSI in the bearish zone, momentum does not favour a quick recovery.
Technical indicators
Momentum and trend for CHTR, from its daily closes.
As of October 27, 2026, with CHTR at $104.92, its 14-day RSI is 39.9 (showing bearish momentum without being oversold), its 50-day simple moving average is $126.67 and its 200-day is $166.30.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CHTR moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, CHTR's 1-year correlation of daily returns is +0.19 with S&P 500 (SPY), +0.08 with Nasdaq 100 (QQQ), +0.00 with Bitcoin (BTC) and -0.06 with gold (XAU).
CHTR price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
5 of 21 analysts rate it a buy or strong buy, 10 a hold and 6 a sell.Median target above the price ›
The median 12-month target of $145.00 is 38.2% above the price.More buy ratings than three months ago ›
5 of 21 rate it a buy now, against 5 of 21 three months ago.
CHTR Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 28, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Sep 14, 2026 | Morgan Stanley | Reinstates | Equal-Weight |
| Sep 14, 2026 | Wolfe Research | Downgrade | Underperform |
| Jul 29, 2026 | JP Morgan | Maintains | Neutral |
| Jul 28, 2026 | Citigroup | Maintains | Buy |
| Jul 27, 2026 | UBS | Maintains | Neutral |
As of October 27, 2026, 21 Wall Street analysts cover CHTR: 5 rate it a buy or strong buy, 10 a hold and 6 a sell or strong sell. Their 12-month price targets range from $68.00 to $380.00. The median CHTR price target is $145.00, 38.2% above the price of $104.92.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CHTR trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CHTR trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CHTR's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CHTR tends to move, against the market and on its own.
CHTR price history and drawdowns
CHTR's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.78% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 87.6%, from September 2021 to October 2026; the price is still 87.2% below that peak.Most 1-year holds ended higher ›
46% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $4,186, against $42,015 in the S&P 500 (SPY).
CHTR Drawdowns & Recovery
As of October 27, 2026, CHTR's worst peak-to-trough fall over the last 10 years with dividends reinvested was -87.6% (September 2021 to October 2026); it is still 87.2% below that peak, and 46% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CHTR in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CHTR trailed the S&P 500 over this period: $4,185.99 against $42,015.
A $10,000 investment in CHTR in October 2016 would be worth about $4,186 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CHTR, and which have not.
Strongest month, July: an average of +3.89%, up in 7 of 10 years.
Weakest month, September: an average of -5.46%, up in 5 of 10 years.
This month, October: has averaged -1.88%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CHTR's strongest calendar month has been July (average +3.89%, up in 7 of 10 years) and its weakest September (average -5.46%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
CHTR stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CHTR, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in CHTR today could grow to about $9,297 by 2030 in the base case, with a 90th-percentile outcome near $23,360 and a 10th-percentile outcome around $3,700. Projections are statistical simulations, not guarantees.
CHTR Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $97.54 for CHTR by 2030 in the base case, from $105 today (0.9x over 4 years). The 10th-percentile path ends near $38.82. These are outcomes of a Monte Carlo simulation run on CHTR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $64.99 | $103 | $163 | |
| 2028 | $52.73 | $101 | $194 | |
| 2029 | $44.73 | $99.33 | $221 | |
| 2030 | $38.82 | $97.54 | $245 |
Method: a lognormal simulation of CHTR's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
CHTR insider trading
What the people running the company have bought and sold.
CHTR insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $4.9M on the open market and sold $13.7M.
As of October 27, 2026, CHTR insiders reported 3 open-market sales worth $13.7M and 6 open-market purchases worth $4.9M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Dallas S Clement
Director
|
Grant | 1.5K | - |
| Aug 19, 2026 | Mark James Greatrex
Director
|
Grant | 1.5K | - |
| May 27, 2026 | Thomas M Rutledge
Director
|
Sell | 87.8K | $12.7M |
| May 15, 2026 | Mauricio Ramos
Director
|
Buy | 9.9K | $1.4M |
| Apr 28, 2026 | Wade Davis
Director
|
Buy | 5.7K | $995.1K |
| Apr 28, 2026 | Balan Nair
Director
|
Buy | 1.0K | $175.5K |
| Apr 28, 2026 | Christopher L Winfrey
Chief Executive Officer
|
Buy | 6.9K | $1.2M |
| Apr 21, 2026 | W Lance Conn
Director
|
Grant | 918 | - |
| Apr 21, 2026 | Wade Davis
Director
|
Grant | 918 | - |
| Apr 21, 2026 | Kim C Goodman
Director
|
Grant | 1.4K | - |
| Apr 21, 2026 | John D Markley Jr
Director
|
Grant | 918 | - |
| Apr 21, 2026 | Steven A Miron
Director
|
Grant | 1.4K | - |
| Apr 21, 2026 | Balan Nair
Director
|
Grant | 1.4K | - |
| Apr 21, 2026 | Michael A Newhouse
Director
|
Grant | 918 | - |
| Apr 21, 2026 | Martin Edward Patterson
Director
|
Grant | 918 | - |
| Apr 21, 2026 | Mauricio Ramos
Director
|
Grant | 918 | - |
| Apr 21, 2026 | Thomas M Rutledge
Divisional Officer
|
Option | 1.6M | $369.6M |
| Apr 21, 2026 | Thomas M Rutledge
Divisional Officer
|
Grant | 1.4K | - |
| Apr 21, 2026 | Carolyn J. Slaski
Director
|
Grant | 918 | - |
| Apr 21, 2026 | J. David Wargo
Director
|
Grant | 918 | - |
| Apr 21, 2026 | Eric Louis Zinterhofer
Director
|
Grant | 2.0K | - |
| Mar 2, 2026 | Kevin D Howard
Officer
|
Grant | 737 | - |
| Jan 27, 2026 | Wade Davis
Director
|
Grant | 279 | - |
| Jan 16, 2026 | Richard J Digeronimo
Officer
|
Grant | 2.6K | - |
| Jan 16, 2026 | Jessica M Fischer
Chief Financial Officer
|
Grant | 1.4K | - |
| Jan 16, 2026 | Kevin D Howard
Officer
|
Option | 6.5K | $1.1M |
| Jan 16, 2026 | Richard Adam Ray
Officer
|
Grant | 774 | - |
| Jan 15, 2026 | Christopher L Winfrey
Chief Executive Officer
|
Option | 24.1K | $4.4M |
| Nov 5, 2025 | David C Merritt
Director
|
Sell | 1.2K | $271.4K |
| Sep 19, 2025 | Richard J Digeronimo
Officer
|
Grant | 234 | - |
| Jul 31, 2025 | Balan Nair
Director
|
Buy | 360 | $98.7K |
| Jul 31, 2025 | Christopher L Winfrey
Chief Executive Officer
|
Buy | 3.7K | $1.0M |
| Jul 25, 2025 | Kevin D Howard
Officer
|
Grant | 52 | - |
| May 16, 2025 | Richard J Digeronimo
Officer
|
Sell | 1.6K | $657.3K |
| May 16, 2025 | Richard J Digeronimo
Officer
|
Option | 9.1K | $2.6M |
Source: TwelveData, from SEC Form 4 filings
CHTR stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.